Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–90.

Voelker R. What is glaucoma? JAMA. 2023;330(16):1594.

Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–11.

Article  PubMed  PubMed Central  Google Scholar 

Jayaram H, Kolko M, Friedman DS, Gazzard G. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788–801.

Lam AKN, To E, Weinreb RN, et al. Use of virtual reality simulation to identify vision-related disability in patients with glaucoma. JAMA Ophthalmol. 2020;138(5):490–8.

Article  PubMed  PubMed Central  Google Scholar 

Marques AP, Ramke J, Cairns J, et al. The economics of vision impairment and its leading causes: a systematic review. EClinical Med. 2022;46: 101354.

Article  Google Scholar 

Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-screening, diagnosis, and management: a review. JAMA. 2021;325(2):164–74.

Article  PubMed  Google Scholar 

Golubnitschaja O, Potuznik P, Polivka J Jr, et al. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach. EPMA J. 2022;13(4):535–45.

Golubnitschaja O, Yeghiazaryan K. Multiomic signature of glaucoma predisposition in flammer syndrome affected individuals – innovative predictive, preventive and personalised strategies in disease management. In: Golubnitschaja O, editor. Flammer syndrome: from phenotype to associated pathologies, prediction, prevention and personalisation. Cham: Springer International Publishing; 2019. pp. 79–104.

Konieczka K, Ritch R, Traverso CE, et al. Flammer syndrome. EPMA J. 2014;5(1):11.

Evsevieva M, Sergeeva O, Mazurakova A, et al. Pre-pregnancy check-up of maternal vascular status and associated phenotype is crucial for the health of mother and offspring. EPMA J. 2022;13(3):351–66.

Bäck M, Yurdagul A Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406.

PubMed  PubMed Central  Google Scholar 

Wang S, Bao X. Hyperlipidemia, blood lipid level, and the risk of glaucoma: a meta-analysis. Invest Ophthalmol Vis Sci. 2019;60(4):1028–43.

Article  PubMed  Google Scholar 

Lee SH, Kim GA, Lee W, Bae HW, Seong GJ, Kim CY. Vascular and metabolic comorbidities in open-angle glaucoma with low- and high-teen intraocular pressure: a cross-sectional study from South Korea. Acta Ophthalmol. 2017;95(7):e564–74.

Article  PubMed  Google Scholar 

Kim M, Jeoung JW, Park KH, Oh WH, Choi HJ, Kim DM. Metabolic syndrome as a risk factor in normal-tension glaucoma. Acta Ophthalmol. 2014;92(8):e637–43.

Article  PubMed  Google Scholar 

Budenz DL, Anderson DR, Feuer WJ, et al. Detection and prognostic significance of optic disc hemorrhages during the ocular hypertension treatment study. Ophthalmology. 2006;113(12):2137–43.

Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y. Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol. 2000;129(6):707–14.

Article  PubMed  CAS  Google Scholar 

Shim SH, Kim JM, Woo HY, Shin KU, Koh JW, Park KH. Association between platelet function and disc hemorrhage in patients with normal-tension glaucoma: a prospective cross-sectional study. Am J Ophthalmol. 2015;160(6):1191-1199.e1.

Article  PubMed  CAS  Google Scholar 

Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology. 2010;117(3):471–6.

Nagaoka T, Takahashi A, Sato E, et al. Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol. 2006;124(5):665–70.

Article  PubMed  CAS  Google Scholar 

Khawaja AP, Cooke Bailey JN, Kang JH, et al. Assessing the association of mitochondrial genetic variation with primary open-angle glaucoma using gene-set analyses. Invest Ophthalmol Vis Sci. 2016;57(11):5046–52.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meguro A, Inoko H, Ota M, Mizuki N, Bahram S. Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology. 2010;117(7):1331–8.e5.

Margeta MA, Yin Z, Madore C, et al. Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma. Immunity. 2022;55(9):1627–44.e7.

Shibata M, Sugiyama T, Hoshiga M, et al. Changes in optic nerve head blood flow, visual function, and retinal histology in hypercholesterolemic rabbits. Exp Eye Res. 2011;93(6):818–24.

Article  PubMed  CAS  Google Scholar 

Fernández-Navarro J, Aldea P, de Hoz R, et al. Neuroprotective effects of low-dose statins in the retinal ultrastructure of hypercholesterolemic rabbits. PLoS ONE. 2016;11(5).

Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89-98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arsenault BJ. From the garden to the clinic: how Mendelian randomization is shaping up atherosclerotic cardiovascular disease prevention strategies. Eur Heart J. 2022;43(42):4447–9.

Article  PubMed  Google Scholar 

Schmidt AF, Finan C, Gordillo-Marañón M, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22(10):658–71.

Article  PubMed  CAS  Google Scholar 

Gill D, Georgakis MK, Koskeridis F, et al. Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation. 2019;140(4):270–9.

Nelson MR, Tipney H, Painter JL, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856–60.

Article  PubMed  CAS  Google Scholar 

Harrison SC, Holmes MV, Burgess S, et al. Genetic association of lipids and lipid drug targets with abdominal aortic aneurysm: a meta-analysis. JAMA Cardiol. 2018;3(1):26–33.

Article  PubMed  Google Scholar 

Williams DM, Finan C, Schmidt AF, Burgess S, Hingorani AD. Lipid lowering and Alzheimer disease risk: A Mendelian randomization study. Ann Neurol. 2020;87(1):30–9.

Article  PubMed  CAS  Google Scholar 

Yarmolinsky J, Bull CJ, Vincent EE, et al. Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer. JAMA. 2020;323(7):646–55.

Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614–21.

Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10(4):486–96.

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251–60.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Zhang B, Liu Q, et al. Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease. EBioMedicine. 2023;90:104543.

Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kettunen J, Demirkan A, Würtz P, et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun. 2016;7:11122.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88.

Article  PubMed  Google Scholar 

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082–143.

Nikpay M, Goel A, Won HH, et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223–42.

Article  PubMed  PubMed Central  Google Scholar 

Fox AR, Fingert JH. Familial normal tension glaucoma genetics. Prog Retin Eye Res. 2023;96: 101191.

Article  PubMed  CAS  Google Scholar 

Leung DYL, Tham CC. Normal-tension glaucoma: Current concepts and approaches-A review. Clin Exp Ophthalmol. 2022;50(2):247–59.

Article  PubMed  Google Scholar 

European Glaucoma Society Terminology and Guidelines for Glaucoma. 5th Edition. Br J Ophthalmol. 2021;105(Suppl 1):1–169.

Weinreb RN, Khaw PT. Primary open-angle glaucoma